vs

Side-by-side financial comparison of Calumet, Inc. (CLMT) and Genpact LTD (G). Click either name above to swap in a different company.

Genpact LTD is the larger business by last-quarter revenue ($1.3B vs $1.0B, roughly 1.3× Calumet, Inc.). Genpact LTD runs the higher net margin — 10.8% vs -3.6%, a 14.4% gap on every dollar of revenue. Genpact LTD produced more free cash flow last quarter ($269.0M vs $103.8M).

Calumet, Inc. is a U.S.-headquartered specialty products firm that manufactures and distributes high-value hydrocarbon and specialty chemical products. Its offerings include specialty oils, lubricants, waxes, and renewable fuel solutions, serving industrial, consumer, and transportation segments across North America.

Genpact Ltd. is an American information technology services, consulting, and outsourcing company headquartered in New York City, New York. Founded in Gurgaon, India, and legally domiciled in Bermuda, Genpact employs more than 125,000 people and provides services to clients in over 30 countries worldwide. Genpact is listed on the NYSE and generated revenues of US$4.48 billion in 2023.

CLMT vs G — Head-to-Head

Bigger by revenue
G
G
1.3× larger
G
$1.3B
$1.0B
CLMT
Higher net margin
G
G
14.4% more per $
G
10.8%
-3.6%
CLMT
More free cash flow
G
G
$165.2M more FCF
G
$269.0M
$103.8M
CLMT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CLMT
CLMT
G
G
Revenue
$1.0B
$1.3B
Net Profit
$-37.3M
$143.1M
Gross Margin
-0.3%
36.6%
Operating Margin
-6.2%
14.8%
Net Margin
-3.6%
10.8%
Revenue YoY
5.6%
Net Profit YoY
0.8%
EPS (diluted)
$-0.43
$0.82

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLMT
CLMT
G
G
Q4 25
$1.0B
$1.3B
Q3 25
$1.1B
$1.3B
Q2 25
$1.0B
$1.3B
Q1 25
$993.9M
$1.2B
Q4 24
$1.2B
Q3 24
$1.1B
$1.2B
Q2 24
$1.1B
$1.2B
Q1 24
$1.1B
Net Profit
CLMT
CLMT
G
G
Q4 25
$-37.3M
$143.1M
Q3 25
$313.4M
$145.8M
Q2 25
$-147.9M
$132.7M
Q1 25
$-162.0M
$130.9M
Q4 24
$141.9M
Q3 24
$-100.6M
$132.8M
Q2 24
$-39.1M
$122.0M
Q1 24
$116.9M
Gross Margin
CLMT
CLMT
G
G
Q4 25
-0.3%
36.6%
Q3 25
34.7%
36.4%
Q2 25
-4.2%
35.9%
Q1 25
-8.2%
35.3%
Q4 24
35.7%
Q3 24
0.4%
35.6%
Q2 24
5.6%
35.4%
Q1 24
35.0%
Operating Margin
CLMT
CLMT
G
G
Q4 25
-6.2%
14.8%
Q3 25
30.0%
14.8%
Q2 25
-9.8%
14.3%
Q1 25
-4.9%
15.1%
Q4 24
15.2%
Q3 24
-5.2%
15.0%
Q2 24
0.5%
14.5%
Q1 24
14.1%
Net Margin
CLMT
CLMT
G
G
Q4 25
-3.6%
10.8%
Q3 25
29.1%
11.3%
Q2 25
-14.4%
10.6%
Q1 25
-16.3%
10.8%
Q4 24
11.4%
Q3 24
-9.1%
11.0%
Q2 24
-3.4%
10.4%
Q1 24
10.3%
EPS (diluted)
CLMT
CLMT
G
G
Q4 25
$-0.43
$0.82
Q3 25
$3.61
$0.83
Q2 25
$-1.70
$0.75
Q1 25
$-1.87
$0.73
Q4 24
$0.80
Q3 24
$-1.18
$0.74
Q2 24
$-0.48
$0.67
Q1 24
$0.64

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLMT
CLMT
G
G
Cash + ST InvestmentsLiquidity on hand
$125.1M
$1.2B
Total DebtLower is stronger
$2.1B
$1.5B
Stockholders' EquityBook value
$-732.7M
$2.5B
Total Assets
$2.7B
$5.8B
Debt / EquityLower = less leverage
0.60×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLMT
CLMT
G
G
Q4 25
$125.1M
$1.2B
Q3 25
$94.6M
$740.8M
Q2 25
$110.6M
$663.3M
Q1 25
$123.4M
$561.6M
Q4 24
$671.6M
Q3 24
$34.6M
$1.0B
Q2 24
$7.0M
$914.2M
Q1 24
$478.4M
Total Debt
CLMT
CLMT
G
G
Q4 25
$2.1B
$1.5B
Q3 25
$2.1B
$1.2B
Q2 25
$2.1B
$1.2B
Q1 25
$2.3B
$1.2B
Q4 24
$1.2B
Q3 24
$1.7B
$1.6B
Q2 24
$1.6B
Q1 24
$1.2B
Stockholders' Equity
CLMT
CLMT
G
G
Q4 25
$-732.7M
$2.5B
Q3 25
$-695.3M
$2.5B
Q2 25
$-1.0B
$2.6B
Q1 25
$-862.3M
$2.5B
Q4 24
$2.4B
Q3 24
$-672.2M
$2.4B
Q2 24
$-566.4M
$2.3B
Q1 24
$2.3B
Total Assets
CLMT
CLMT
G
G
Q4 25
$2.7B
$5.8B
Q3 25
$2.7B
$5.4B
Q2 25
$2.8B
$5.3B
Q1 25
$2.8B
$4.9B
Q4 24
$5.0B
Q3 24
$2.6B
$5.3B
Q2 24
$100
$5.2B
Q1 24
$4.7B
Debt / Equity
CLMT
CLMT
G
G
Q4 25
0.60×
Q3 25
0.47×
Q2 25
0.47×
Q1 25
0.50×
Q4 24
0.51×
Q3 24
0.68×
Q2 24
0.70×
Q1 24
0.54×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLMT
CLMT
G
G
Operating Cash FlowLast quarter
$116.5M
$286.7M
Free Cash FlowOCF − Capex
$103.8M
$269.0M
FCF MarginFCF / Revenue
10.0%
20.4%
Capex IntensityCapex / Revenue
1.2%
1.3%
Cash ConversionOCF / Net Profit
2.00×
TTM Free Cash FlowTrailing 4 quarters
$56.6M
$734.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLMT
CLMT
G
G
Q4 25
$116.5M
$286.7M
Q3 25
$23.5M
$308.4M
Q2 25
$-1.8M
$177.4M
Q1 25
$-29.3M
$40.4M
Q4 24
$203.2M
Q3 24
$-15.5M
$228.5M
Q2 24
$209.3M
Q1 24
$-25.6M
Free Cash Flow
CLMT
CLMT
G
G
Q4 25
$103.8M
$269.0M
Q3 25
$15.1M
$292.0M
Q2 25
$-15.4M
$155.1M
Q1 25
$-46.9M
$18.5M
Q4 24
$183.5M
Q3 24
$-32.2M
$208.7M
Q2 24
$190.0M
Q1 24
$-49.6M
FCF Margin
CLMT
CLMT
G
G
Q4 25
10.0%
20.4%
Q3 25
1.4%
22.6%
Q2 25
-1.5%
12.4%
Q1 25
-4.7%
1.5%
Q4 24
14.7%
Q3 24
-2.9%
17.2%
Q2 24
16.2%
Q1 24
-4.4%
Capex Intensity
CLMT
CLMT
G
G
Q4 25
1.2%
1.3%
Q3 25
0.8%
1.3%
Q2 25
1.3%
1.8%
Q1 25
1.8%
1.8%
Q4 24
1.6%
Q3 24
1.5%
1.6%
Q2 24
2.2%
1.6%
Q1 24
2.1%
Cash Conversion
CLMT
CLMT
G
G
Q4 25
2.00×
Q3 25
0.07×
2.11×
Q2 25
1.34×
Q1 25
0.31×
Q4 24
1.43×
Q3 24
1.72×
Q2 24
1.72×
Q1 24
-0.22×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLMT
CLMT

Specialty Products And Solutions$675.9M65%
Montana Renewables$294.2M28%
Performance Brands$68.5M7%

G
G

High Tech And Manufacturing$525.3M40%
Consumer And Healthcare$445.8M34%
Financial Services$348.2M26%

Related Comparisons